KRAS and neoplasm: Presumably, the presence of most neoantigens might be attribute to their high mutation frequency, for which drive effects caused by KRAS p.G12V, and other pathogenic mutations might be lowered partially under a stronger anti-tumor immunity triggered by augmented neoantigens, resulting in prolonged PFS after surgery and accompanied higher NCF at certain time-points of Pt204.